Unraveling Mechanisms and Epidemic Characteristics of Nitrofurantoin Resistance in Uropathogenic Enterococcus faecium Clinical Isolates

References

• Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10(4):266–278. doi:10.1038/nrmicro276122421879
   PubMed Web of Science ®Google Scholar
• García-Solache M, Rice LB. The Enterococcus: a Model of Adaptability to Its Environment. Clin Microbiol Rev. 2019;32(2):e00058–18.30700430
   PubMed Web of Science ®Google Scholar
• Raza T, Ullah SR, Mehmood K, Andleeb S. Vancomycin resistant Enterococcus: a brief review. J Pak Med Assoc. 2018;68(5):768–772.29885179
   PubMed Web of Science ®Google Scholar
• Shrestha LB, Baral R, Poudel P, Khanal B. Clinical, etiological and antimicrobial susceptibility profile of pediatric urinary tract infections in a tertiary care hospital of Nepal. BMC Pediat. 2019;19(1):36. doi:10.1186/s12887-019-1410-1
   Web of Science ®Google Scholar
• O’Brien VP, Hannan TJ, Nielsen HV, Hultgren SJ. Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr. 2016;4(1):10.1128. doi:10.1128/microbiolspec.UTI-0013-2012
   PubMed Web of Science ®Google Scholar
• Cattoir V, Leclercq R. Twenty-five years of shared life with vancomycin-resistant Enterococcus: is it time to divorce? J Antimicrob Chemother. 2013;68(4):731–742. doi:10.1093/jac/dks46923208830
   PubMed Web of Science ®Google Scholar
• Miller WR, Munita JM, Arias CA. Mechanisms of antibiotic resistance in. Enterococcus Expert Rev Anti Infect Ther. 2014;12(10):1221–1236. doi:10.1586/14787210.2014.95609225199988
   PubMed Web of Science ®Google Scholar
• Kilbas I, Ciftci IH. Antimicrobial resistance of Enterococcus isolates in Turkey: a meta-analysis of current studies. J Glob Antimicrob Resist. 2018;12:26–30. doi:10.1016/j.jgar.2017.08.01228882763
   PubMed Web of Science ®Google Scholar
• Yim J, Smith JR, Rybak MJ. Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections. Review of the Current Evidence. Pharmacotherapy. 2017;37(5):579–592. doi:10.1002/phar.192228273381
   PubMed Web of Science ®Google Scholar
• Wijma RA, Huttner A, Koch BCP, Mouton JW, Muller AE. Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline. J Antimicrob Chemother. 2018;73(11):2916–2926. doi:10.1093/jac/dky25530184207
   PubMed Web of Science ®Google Scholar
• Zayyad H, Eliakim-Raz N, Leibovici L, Paul M. Revival of old antibiotics: needs, the state of evidence and expectations. Int J Antimicrob Agents. 2017;49(5):536–541. doi:10.1016/j.ijantimicag.2016.11.02128162982
   PubMed Web of Science ®Google Scholar
• Vervoort J, Xavier BB, Stewardson A, et al. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother. 2014;58(12):7225–7233. doi:10.1128/AAC.03952-1425246406
   PubMed Web of Science ®Google Scholar
• Meena S, Mohapatra S, Sood S, Dhawan B, Das BK, Kapil A. Revisiting Nitrofurantoin for Vancomycin-resistant Enterococcus. J Clin Diagn Res. 2017;11(6):DC19–DC22. doi:10.7860/JCDR/2017/25140.10140
   PubMed Web of Science ®Google Scholar
• Osei Sekyere J. Genomic insights into nitrofurantoin resistance mechanisms and epidemiology in clinical Enterobacteriaceae. Future Sci OA. 2018;4(5):FSO293. doi:10.4155/fsoa-2017-015629796297
   PubMed Web of Science ®Google Scholar
• Xu Q, Jiang J, Zhu Z, et al. Efflux pumps AcrAB and OqxAB contribute to nitrofurantoin resistance in a uropathogenic Klebsiella pneumoniae isolate. Int J Antimicrob Agents. 2019;54(2):223–227. doi:10.1016/j.ijantimicag.2019.06.00431200021
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang Y, Wang F, et al. Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates. Int J Antimicrob Agents. 2018;52(2):226–232. doi:10.1016/j.ijantimicag.2018.04.02129753133
   PubMed Web of Science ®Google Scholar
• Amladi AU, Abirami B, Devi SM, et al. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections. Indian J Med Res. 2019;149(2):185–191. doi:10.4103/ijmr.IJMR_2086_1731219082
   PubMed Web of Science ®Google Scholar
• Mortl S, Fischer M, Richter G, Tack J, Weinkauf S, Bacher A. Biosynthesis of riboflavin: lumazine synthase of. Escherichia Coli J Biol Chem. 1996;271:33201–33207. doi:10.1074/jbc.271.52.332018969176
   PubMed Web of Science ®Google Scholar
• Chalansonnet V, Mercier C, Orenga S, Gilbert C. Identification of Enterococcus faecium enzymes with azoreductases and/or nitroreductase activity. BMC Microbiol. 2017;17(1):126. doi:10.1186/s12866-017-1033-328545445
   PubMed Web of Science ®Google Scholar
• Rafii F, Wynne R, Heinze TM, Paine DD. Mechanism of metronidazole-resistance by isolates of nitroreductase-producing Enterococcus gallinarum and Enterococcus casseliflavus from the human intestinal tract. FEMS Microbiol Lett. 2003;225(2):195–200. doi:10.1016/S0378-1097(03)00513-512951241
   PubMed Web of Science ®Google Scholar
• Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs. 2004;64(2):159–204.14717618
   PubMed Web of Science ®Google Scholar
• Shiadeh SMJ, Hashemi A, Fallah F, Rashidan M. First detection of efrAB, an ABC multidrug efflux pump in Enterococcus faecium in Tehran, Iran. Acta Microbiol Immunol Hung. 2019;66(1):57–68. doi:10.1556/030.65.2018.01630246548
   PubMed Web of Science ®Google Scholar
• Sánchez Valenzuela A, Lavilla Lerma L, Benomar N, et al. Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods. Foodborne Pathog Dis. 2013;10:143–149. doi:10.1089/fpd.2012.127923259502
   PubMed Web of Science ®Google Scholar
• Djahmi N, Boutet-Dubois A, Nedjai S, Dekhil M, Sotto A, Lavigne JP. Molecular epidemiology of Enterococcus sp. isolated in a university hospital in Algeria. Scand J Infect Dis. 2012;44(9):656–662. doi:10.3109/00365548.2012.67323222568723
   PubMed Web of Science ®Google Scholar
• Zhang X, Bi W, Chen L, et al. Molecular mechanisms and epidemiology of fosfomycin resistance in Enterococcus isolated from patients at a teaching hospital in China, 2013–2016. J Glob Antimicrob Resist. 2020;20:191–196. doi:10.1016/j.jgar.2019.08.00631422238
   PubMed Web of Science ®Google Scholar
• Cassir N, Rolain JM, Brouqui P. A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol. 2014;5:551. doi:10.3389/fmicb.2014.0055125368610
   PubMed Web of Science ®Google Scholar
• Matthews PC, Barrett LK, Warren S, et al. Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study. BMC Infect Dis. 2016;16(1):556. doi:10.1186/s12879-016-1888-127729016
   PubMed Web of Science ®Google Scholar
• Beckford-Ball J. Management of suspected bacterial urinary tract infection. Nurs Times. 2006;102(36):25–26.
   Google Scholar
• Cunha BA, Cunha CB, Lam B, et al. Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications. Eur J Clin Microbiol Infect Dis. 2017;36(7):1213–1216. doi:10.1007/s10096-017-2911-128155015
   PubMed Web of Science ®Google Scholar
• Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother. 2015;70(9):2456–2464. doi:10.1093/jac/dkv14726066581
   PubMed Web of Science ®Google Scholar
• McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother. 1994;33:23–30. doi:10.1093/jac/33.suppl_A.237928834
   PubMed Web of Science ®Google Scholar
• Yuan L, Zhai YJ, Wu H, et al. Identification and prevalence of RND family multidrug efflux pump oqxAB genes in Enterococci isolates from swine manure in China. J Med Microbiol. 2018;67(6):733–739. doi:10.1099/jmm.0.00073629687766
   PubMed Web of Science ®Google Scholar
• Li J, Zhang H, Ning J, et al. The nature and epidemiology of oqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control. 2019;8:44.30834112
   PubMed Web of Science ®Google Scholar
• Jonas BM, Murray BE, Weinstock GM. Characterization of emeA, a NorA homolog and multidrug resistance efflux pump, in Enterococcus faecalis. Antimicrob Agents Chemother. 2001;45(12):3574–3579. doi:10.1128/AAC.45.12.3574-3579.200111709342
   PubMed Web of Science ®Google Scholar